HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway - Wikidata - awgldk - TriplyDB

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

http://www.wikidata.org/entity/Q24323992

about

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL APOE genotype and stress response - a mini review Proteomics investigations of HDL: challenges and promise JTT-705: is there still future for a CETP inhibitor after torcetrapib?Relationship between Serum Vitamin D Status and Metabolic Risk Factors among Korean Adults with Prediabetes Association between Six CETP Polymorphisms and Metabolic Syndrome in Uyghur Adults from Xinjiang, China.5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo.Xanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP-transgenic mice.Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet.Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin.Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration Association between vitamin D status and risk of metabolic syndrome among Korean postmenopausal women.Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet).eNOS activation by HDL is impaired in genetic CETP deficiency.Molecular regulation of HDL metabolism and function: implications for novel therapies.ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters.ApoA-1 in diabetes: damaged goods.Future therapeutic directions in reverse cholesterol transport.Novel HDL-directed pharmacotherapeutic strategies.Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis.High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1 Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women.Cholesteryl ester transfer protein (CETP) I405V polymorphism and cardiovascular disease in eastern European Caucasians - a cross-sectional study Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver.Novel biological functions of high-density lipoprotein cholesterol SR-BI associates with ABCG1 and inhibits ABCG1-mediated cholesterol efflux from cells to high-density lipoprotein 3.Cholesterol efflux analyses using stable isotopes and mass spectrometry.ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase.CETP inhibition in cardiovascular risk management: a critical appraisal.Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.Thermal transitions in human very-low-density lipoprotein: fusion, rupture, and dissociation of HDL-like particles.In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.

P2860

07e72e878b929547a33e6795d72c09f3d8370017 101911bd9358124e04b3946e32b4d018cf22adc8 faa1ad2bd696dae3a391c68df6fa6c55961fd4e4

P248

Q24634165-DD9669B0-BBF6-4F8C-8B12-5AE17D51BD3B Q24669594-E20B8C0D-1215-4036-B6DD-E31B9BD25DCB Q26741633-2923DF16-2E52-4535-98ED-8B0A0A6E6E74 Q27000995-D69FC4C0-B800-41C8-8C1E-D893BE1A68DA Q28294797-9B9D12EB-DDBF-4E71-90B3-7579E03C3CBA Q28552978-DABB25FC-18FB-481E-9B3B-52EA0DF22CB1 Q33839977-86E73441-3326-4AA0-A52D-FD1D7E85D68F Q34035255-ECCA660C-71ED-4490-B2DC-5A1A372643FF Q34155049-A8B2E9F5-C142-4933-8442-4B42EF2E6596 Q34395133-17D448A9-0634-4038-AF43-E859C8A814DD Q34482324-3047A401-F5C8-4A44-AB6F-FBE83718FFCC Q34537191-10AB8FA5-C939-49AA-A0E4-52454F7090D6 Q34628218-2EF12F59-AF8A-4B5F-91E7-AEFB9CB418CD Q34657417-A23A2297-2596-4C65-8A15-57B91B26463E Q34797618-89B1F894-8FFC-4274-8958-C8ACBB5F3E2E Q34858025-315152F9-4F88-4D20-9DA9-A9F8A8185F45 Q35084411-98E4F5FF-7A06-4809-B1EF-79CC19784A4D Q35107958-22730DE0-E87D-4EFA-8A56-617BF7A84830 Q35108988-7965A888-2056-47E5-8EFB-FA841E803448 Q35168995-66AE5FB4-61FC-4AF0-8654-7658BE491AE1 Q35191066-85D08B2D-1A37-42A2-9EA1-B7A868FD232B Q35370268-0FB5716B-A000-4E7E-9EEB-21A645C356B6 Q35380101-895A587F-5151-4B80-8867-76AB42533920 Q35757158-387B37E0-F854-4A50-B75A-A0D3E5D74838 Q35860010-4D509EFA-D16A-4D5D-ABDC-EF4B3785B921 Q35860020-9377DEFC-1880-4C3E-9BD4-588D05132325 Q35897068-EF686C63-489A-441C-86B2-1DE3509CE26C Q36002630-FCED5783-8B3C-42B7-81E5-8F3A6085422E Q36037988-044427AF-3458-4B3E-AD91-43DF14826BB3 Q36078185-D80428DD-A317-410A-AD1F-D956A5D3E64E Q36083105-1C4F085F-D221-45C7-9AF2-527B73921FBB Q36302709-BFB4EC4A-E88C-4AF9-8344-F1F9EF38C6B3 Q36406480-639561D4-0B8C-4BA4-8FB1-D656251FC86F Q36440709-EAE44E58-3229-4920-AFD7-8F7F54A8CF98 Q36480687-EF495C86-CC3F-4E91-94B4-E78C99B067A0 Q36682924-5623802F-251D-4DA0-BDED-3545728A2AE7 Q36705260-AB45FFBD-6DBE-44FD-B09E-0840360336AB Q36858466-6B09ED66-146B-468F-837E-B8527F4EE9D8 Q36960880-F38A1769-F0A8-47CA-9BDE-AEAB3D14B500 Q37163072-124EF15D-53A3-44D5-BA38-90235087B858

P2860

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

http://www.wikidata.org/entity/Q24323992

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@ast

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@en

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@en-gb

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@nl

type

label

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@ast

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@en

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@en-gb

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@nl

prefLabel

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@ast

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@en

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@en-gb

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@nl

P1433

Q24323992-089D59F5-63A7-4B78-9044-BD73E226AFCD

P1476

Q24323992-75C3403D-5A8A-4D9B-A21C-44C43756060F

P2093

Q24323992-04668855-8D26-4758-8B40-4F527B91D20B

Q24323992-2DDDC079-E4A9-4B5C-B407-030A31082096

Q24323992-3453CEC6-0A3F-4B78-8779-7BBA4309E276

Q24323992-39CB4D85-766A-400A-BB5E-8F7371BB64D9

Q24323992-83895D04-C10E-48DE-B5E5-5C6835829722

P2860

Q24323992-1BE80B4D-2F9F-4E48-B9A2-060E0725A17A

Q24323992-40ED5CDF-E0E4-463B-8366-478CACF20CFF

Q24323992-6ADEB13D-5BFB-4D98-BEF0-502364E95438

Q24323992-6C3BE624-2366-4C8F-A2A5-7355464CF5D1

Q24323992-8088DD9A-7F13-41AD-9119-DB4060C9AB17

Q24323992-8ED85C63-847C-40A9-9A96-4AE60C29390B

Q24323992-9036FCC1-91DE-49E6-8034-153AD751C062

Q24323992-92FEC5D0-A237-4C61-AADD-C5F1E692C3B3

Q24323992-943C3339-D8BC-4D08-9868-A448154F5C27

Q24323992-99EA03EB-BC97-4D2A-A59A-207FC731A080

P304

Q24323992-03A5279F-7FB1-4E32-8DF8-091F80680BC0

P31

Q24323992-771166B1-B8DB-4BFB-ADE6-BBBCA50DB0C6

P3181

Q24323992-59BF77C0-2D5E-4674-8E2E-62F75A14E13B

P356

Q24323992-6B871161-FF00-440A-9124-180496B4F554

P407

Q24323992-C72510A7-5C3D-40F7-A3FE-99F41BE75E3D

P433

Q24323992-BEB8B13E-AC2C-4F7E-85AB-FD37B4045357

P478

Q24323992-1314CE28-70E2-4E5F-92A1-99AF22309064

P577

Q24323992-73263EFE-AC3D-425A-8410-B87C5B314EB8

P698

Q24323992-28D9206C-8E6C-4D7E-A0E1-FA53809AFC44

P921

Q24323992-005D3A82-7688-4461-84FF-FA77D712873C

Q24323992-0CE7BA91-6CCC-4F43-9DBB-54AB23B5180E

Q24323992-1E1E605E-BC0C-4956-AE87-4D5B8FD69B67

P932

Q24323992-27DDFACD-9D6C-4BCA-95A7-E4648FB773FB

P3181

P356

P1433

Journal of Clinical Investigation

P1476

HDL from CETP-deficient subjec ...... E- and ABCG1-dependent pathway

@en

P2093

Alan R Tall

http://www.w3.org/2001/XMLSchema#string

Fumihiko Matsuura

http://www.w3.org/2001/XMLSchema#string

Nan Wang

http://www.w3.org/2001/XMLSchema#string

Wengen Chen

http://www.w3.org/2001/XMLSchema#string

Xian-Cheng Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein

Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins

Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.

P304

1435-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

33038

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI27602

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16670775

http://www.w3.org/2001/XMLSchema#string

P921

regulation of cholesterol efflux

Cholesteryl ester transfer protein

P932

1451209

http://www.w3.org/2001/XMLSchema#string